DENTSPLY SIRONA (NASDAQ:XRAY) Announces Quarterly Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY) issued its earnings results on Thursday. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02), FiscalAI reports. The company had revenue of $836.00 million for the quarter, compared to analyst estimates of $861.68 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. DENTSPLY SIRONA updated its FY 2026 guidance to 1.200-1.300 EPS.

Here are the key takeaways from DENTSPLY SIRONA’s conference call:

• DENTSPLY SIRONA lowered its 2026 outlook: sales are now expected to be approximately $3.5 billion, and adjusted EPS $1.20–$1.30, down from prior ranges of $3.5–$3.6 billion and $1.40–$1.50, respectively.
• Q3 revenue fell 7% in constant currency to $836 million, and adjusted EPS declined to $0.29 from $0.42 a year ago. Dental businesses faced lower volumes, planned dealer inventory reductions, and pressure in EMEA.
• Operating cash flow decreased to $32 million from $79 million, primarily due to unfavorable working capital; net debt to EBITDA was 3.4, and management said debt reduction remains a priority.
• Q3 results included a $39 million pre-tax accounting benefit from refining estimates of intercompany profit in inventory transfers; management said it reflects multiple years, is not expected to recur, and is included in the updated EPS outlook.
• Management cited early growth areas, including record Wellspect sales, up 10%, double-digit U.S. growth in MIS implants, and a return to growth in U.S. endodontics. It is expanding sales coverage and clinical education, while cautioning that broader, sustained improvement is still needed.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.56 during trading hours on Thursday, hitting $10.09. The stock had a trading volume of 7,842,097 shares, compared to its average volume of 4,910,103. The company has a 50-day moving average of $9.65 and a two-hundred day moving average of $11.30. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The company has a market cap of $2.01 billion, a PE ratio of -3.67, a price-to-earnings-growth ratio of 1.25 and a beta of 0.87. DENTSPLY SIRONA has a fifty-two week low of $8.32 and a fifty-two week high of $14.76.

Analysts Set New Price Targets

XRAY has been the topic of several analyst reports. Mizuho dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday, October 22nd. Barclays increased their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Piper Sandler dropped their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, October 9th. BMO Capital Markets dropped their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday, September 17th. Finally, Barrington Research cut their price target on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 26th. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $12.62.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.